Condition: Healthy Controls · Brain Function · Sponsor: HealthTech Connex Inc.
The purpose of this study is to understand how the brain responds to sounds and words, and how this response varies between individuals. The purpose if this study is to develop data set comparing the results from one individual with those from other members (a reference interval database of NeuroCatch® Platform 2) and to quantify the expected distribution across sex and age. NeuroCatch® Platform 2, is a medical device approved by Health Canada. The plan is to enroll 810 participants, the study includes screening for eligibility and one brain scan. The study is conducted at the Centre for Neurology Studies in Surrey, BC or at its satellite sites ( if required).
This description comes directly from the study's public registry record.
Sonia Brodie · 604-308-5900 · cnsneurostudies@gmail.com
Monica Vo · 778-735-1986 · cnsneurostudies@gmail.com
Always discuss trial participation with your own doctor first.
| Centre for Neurology Studies, 13761 96 Ave, Unit 1004 | Surrey, British Columbia, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06677424